https://clinicaltrials.gov/ct2/show/NCT04674735
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere’s Disease
Clinical Trials
Ménière’s Disease Registry (MDR) [Observational]
https://clinicaltrials.gov/ct2/show/NCT04438538
Go to sections
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Risk Factors for the Development of Bilateral Ménière’s Disease and the Establishment of a National Ménière’s Disease Registry.
Actual Study Start Date : June 20, 2020
Estimated Primary Completion Date : February 1, 2021
Estimated Study Completion Date : February 1, 2021
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT03664674
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere’s Disease
Previous update: October 10, 2019
Recent update: March 6, 2020
Updated on June 17, 2020 – new study location(s) added
A Study of a Mastoid Device in Subjects With Ménière’s Disease
https://clinicaltrials.gov/ct2/show/NCT03520322?type=Intr&cond=Meniere+Disease&lupd_s=01%2F29%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Device: Mastoid Oscillator; Device: Control Device
Sponsor : University of Rochester
Enrolling by invitation
A Study of a Mastoid Device in Subjects With Ménière’s Disease
NCT03520322
Wed, 09 May 2018 12:00:00 EDT
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
https://clinicaltrials.gov/ct2/show/NCT04218123?type=Intr&cond=Meniere+Disease&lupd_s=12%2F23%2F2019&lupd_d=14
Condition : Meniere Disease
Interventions : Drug: Venlafaxine; Drug: Placebo oral tablet
Sponsors : Medical University of South Carolina; American Hearing Research Foundation
Not yet recruiting
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere’s Disease Outcomes
NCT04218123
Mon, 06 Jan 2020 12:00:00 EST
SPI-1005 for the Treatment of Patients With Meniere’s Disease [Completed]
https://clinicaltrials.gov/ct2/show/NCT03325790?type=Intr&cond=Meniere+Disease&lupd_s=06%2F04%2F2019&lupd_d=14
Condition : Meniere’s Disease
Interventions : Drug: 200mg SPI-1005 BID; Drug: 400mg SPI-1005 BID; Other: Placebo
Sponsor : Sound Pharmaceuticals, Incorporated
Completed
SPI-1005 for the Treatment of Patients With Meniere’s Disease
NCT03325790
Mon, 30 Oct 2017 12:00:00 EDT
Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease
https://clinicaltrials.gov/ct2/show/NCT03795675?type=Intr&cond=Meniere+Disease&lupd_s=02%2F28%2F2019&lupd_d=14
Cochlear Implantation During Vestibular Schwannoma Removal or During Labyrinthectomy Surgery for Treatment of Meniere’s Disease
Conditions : Vestibular Schwannoma; Meniere Disease
Intervention : Device: Cochlear Implant
Sponsors : Ohio State University; Advanced Bionics
Recruiting
CI Following VS Removal or Labyrinthectomy
NCT03795675
Tue, 08 Jan 2019 12:00:00 EST
Transcranial Vibrating System for Improving Vestibular Physical Therapy
https://clinicaltrials.gov/ct2/show/NCT03795168
Transcranial Vibrating System for Improving Vestibular Physical Therapy
